000			01581nam a2200301 4500
001			ESSALUD
005			20260804163623.0
007			ta
008			t pe ||||| |||| 00| 0 spa d
040			_aBMG
041			_aeng
100			_aWilliams, David A. _eAutor _953761
245			_aFibromyalgia
300			_apáginas: 267-277
520			_aFibromyalgia is characterized by widespread pain involving any body tissue and typically accompanied by fatigue and problems with sleep, mood, and memory. Fibromyalgia can occur alone or in combination with other chronic overlapping primary pain conditions, or it can be superimposed on other conditions, such as autoimmune disorders (secondary pain). In fibromyalgia, the central nervous system (CNS) is hyperresponsive to sensory stimuli generally. Successful pharmacologic and nonpharmacologic interventions focus on the CNS to support CNS quiescence and a return to homeostasis. Although fibromyalgia is rarely curable, most cases can be well managed in the context of primary care.
650			_aMEDICINA DEL ADOLESCENTE _95533
650			_aMEDICINA CLÍNICA _933681
650			_aMEDICINA CLÍNICA AMBULATORIA _953762
650			_aENFERMEDAD NEUROMUSCULAR _953763
650			_aENDOCRINOLOGÍA _936891
650			_aNEUROLOGÍA
650			_aDOLOR
650			_aPEDIATRÍA _96401
650			_aPSIQUIATRÍA _95413
700			_aClauw, Daniel J. _953764
773	0		_022717 _922636 _dMassachusetts NEJM Group _oNEJM003 _tThe New England Journal of Medicine _wESSALUD _x0028-4793
942			_cARTICULOS _e2026-07-31 _zSQB
999			_c22740 _d22740